Current and future treatment of amyloid neuropathies.

Abstract excerpt

Amyloid neuropathies of acquired or genetic origin are disabling and life-threatening, until recently there were few treatment options available. Poor prognosis is related to progressive neuropathy and associated, although often underdiagnosed, cardiac involvement in specific transthyretin (TTR) gene mutations. Recent progress has modified prognosis and management of amyloid neuropathies. In TTR-familial...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Amyloid Neuropathies
• Share to TTR gene
• Share to Genetic Therapy